Why does my life insurance application keep getting kicked to manual review?
Explore the reasons for life insurance manual review delays, from thin health data to ambiguous records, and how biometric data can accelerate underwriting.
Life insurance carriers have invested billions in accelerated underwriting platforms with the promise of instant decisions. The goal is a faster, more efficient process that improves applicant experience and lowers acquisition costs. Yet, for a significant number of applicants, the "instant" journey ends abruptly with a notification that their case has been referred for manual review. This detour creates the very friction and frustration the new systems were designed to eliminate. The primary culprit is often not a major health condition, but a simple lack of data-or rather, a lack of the right kind of data needed to make a confident, automated decision. For chief underwriting officers, this fallout represents a critical challenge, eroding the ROI of technology investments and creating a persistent life insurance manual review delay for a large segment of the market.
"Globally, the average success rate for applications processed through automated underwriting engines is approximately 75%, with some markets reaching up to 90%. This means at least one in four, and in some regions more, of all 'accelerated' applications fall out of the automated path and require manual intervention." - Swiss Re, "Reimagining life insurance underwriting," 2022
The anatomy of a life insurance manual review delay
The modern underwriting process is a data waterfall. An automated rules engine attempts to build a comprehensive risk profile by pulling data from a sequence of third-party sources: pharmacy (Rx) databases, the Medical Information Bureau (MIB), and public records. When this data is clean, consistent, and complete, the engine can confidently approve the application or triage it appropriately within seconds.
The problem arises when the data is ambiguous. An MIB code indicates a potential condition reported on a past application, but it provides no context on the outcome or severity. An Rx history might show a prescription for a drug used to treat multiple conditions, from mild to severe. The automated system flags these as potential risks, but it cannot resolve the ambiguity on its own. Unable to proceed, its only option is to flag the application for a human underwriter. This is the origin of the life insurance manual review delay. The system isn't broken; it's working as designed, but it's operating with incomplete information.
The result is a costly and slow process that defeats the purpose of acceleration. The human underwriter must then begin the traditional, time-consuming process of ordering an Attending Physician Statement (APS) or other records to resolve the ambiguity the automated system could not.
| Trigger for Manual Review | Signal for Automated Approval |
|---|---|
| Ambiguous prescription history (e.g., off-label drug use) | Clean prescription history from a verified digital source |
| MIB code without corroborating health data | No MIB codes or codes validated by current health data |
| Inconsistent data across sources (e.g., application vs. public records) | Consistent and verifiable data across all digital sources |
| Thin data file (e.g., young applicant, new resident) | Verifiable biometric data (e.g., contactless vitals scan) |
| Application details exceed automated risk thresholds | Face amount and applicant data align with pre-set actuarial models |
Industry applications: reducing manual review rates
For carriers, reducing the rate of manual review is a direct path to improving profitability and customer satisfaction. The key is not to remove checkpoints, but to provide automated systems with better data to navigate them.
Augmenting the data waterfall
The current data waterfall is passive; it relies on historical data that may be incomplete or outdated. A more effective approach involves actively generating new, verifiable data points during the application process itself. By integrating a real-time data capture step, carriers can give the underwriting engine the information it needs to resolve the exact ambiguities that would otherwise trigger a manual review.
The role of verifiable biometric data
This is where real biometric data becomes a critical tool. Rather than relying solely on inferred health status from historical Rx data, carriers can use applicant-provided data from a brief smartphone scan to get a current, verifiable snapshot of their health. This includes key vitals like blood pressure, heart rate, and respiratory rate. This "ground truth" data provides immediate context. For example:
- An ambiguous prescription for a beta-blocker (which could be for hypertension or anxiety) can be contextualized by a real-time blood pressure reading that is well within the normal range.
- A thin data file on a young applicant can be substantially enriched with a verifiable BMI and heart rate variability assessment.
- Concerns about smoking or other lifestyle risks can be partially mitigated by clear cardiorespiratory indicators.
This allows the automated engine to clear flags in real time, keeping the application on the accelerated path and preventing the life insurance manual review delay before it even begins.
Current research and evidence
Industry research supports the move toward more data-rich underwriting. Studies by McKinsey have highlighted that digital and AI-powered underwriting can significantly improve accuracy and efficiency. Their research points to systems where straight-through processing rates are climbing, but only when fueled by robust data inputs.
A 2020 LIMRA study found that a lack of automation was a specific cause for customer dissatisfaction, indicating a clear market demand for faster, more transparent processes. The data shows that applicants who start an accelerated journey only to be diverted to a manual one are often highly frustrated. Providing the tools to keep more applicants in the automated workflow directly addresses this core business challenge. The evidence suggests that the carriers who succeed will be those who can most effectively use data to resolve uncertainty.
The future of underwriting automation
The future of underwriting is not about eliminating underwriters, but about elevating their role. By using technology to handle the clear-cut cases, underwriters can focus their expertise on the truly complex, high-value applications where human judgment is essential. The trend is toward a dynamic underwriting system where an AI engine, fueled by real-time biometric data, can make an instant decision on a growing majority of cases. This creates a virtuous cycle: higher automation leads to lower costs, better customer experience, and more time for underwriters to spend on strategic risks.
Frequently asked questions
What is the most common reason for a life insurance manual review delay?
The most frequent trigger is a discrepancy or ambiguity between the information provided on the application and the data retrieved from third-party sources like pharmacy records (Rx) or the Medical Information Bureau (MIB). The automated system flags this inconsistency for a human to resolve.
As a carrier, how can I reduce my manual review rate?
Reducing manual review rates involves enriching the data available to your automated underwriting engine. By integrating real-time, applicant-provided data, such as biometric information from a smartphone scan, you can give your system the tools to resolve ambiguities automatically and increase your straight-through-processing percentage.
Does "accelerated underwriting" mean no human ever sees the application?
Not always. It means an algorithm makes the first pass. If the algorithm is highly confident due to clean and complete data, it can issue an approval without human intervention. However, if it encounters missing or conflicting data, it creates a life insurance manual review delay by flagging the case for a human underwriter.
The challenge of reducing manual override rates is a critical focus for today's top carriers. At Circadify, we are building solutions that address this problem head-on, providing the real, verifiable biometric data needed to increase underwriting automation, reduce delays, and keep more applicants on the instant-issue path. To learn more about how real-time health data is enabling the next generation of accelerated underwriting, visit circadify.com/industries/payers-insurance.